Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France
出版年份 2016 全文链接
标题
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France
作者
关键词
-
出版物
mAbs
Volume 8, Issue 6, Pages 999-1009
出版商
Informa UK Limited
发表日期
2016-06-07
DOI
10.1080/19420862.2016.1196521
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors
- (2016) Clément Grandin et al. ANTIVIRAL RESEARCH
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
- (2016) Maria-Elisabeth Goebeler et al. LEUKEMIA & LYMPHOMA
- CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications
- (2016) Anke Steinmetz et al. mAbs
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- A Novel Nonhuman Primate Model of Cigarette Smoke–Induced Airway Disease
- (2015) Francesca Polverino et al. AMERICAN JOURNAL OF PATHOLOGY
- Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
- (2015) Laurent Detalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protective role for club cell secretory protein-16 (CC16) in the development of COPD
- (2015) Maria E. Laucho-Contreras et al. EUROPEAN RESPIRATORY JOURNAL
- Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection
- (2015) Jennifer Kearley et al. IMMUNITY
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
- (2015) Luis Paz-Ares et al. LANCET ONCOLOGY
- Antibodies to watch in 2016
- (2015) Janice M. Reichert mAbs
- Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
- (2015) Mélanie Bruchard et al. NATURE IMMUNOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation
- (2015) Fahima Madouri et al. Journal of Molecular Cell Biology
- Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
- (2015) E. Suzanne Cohen et al. Nature Communications
- Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
- (2015) Maria E. Laucho-Contreras et al. Jove-Journal of Visualized Experiments
- Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab
- (2015) Rita De Santis et al. Oncotarget
- Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
- (2014) Y.-A. Que et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract
- (2014) Salome Juliette Koussoroplis et al. JOURNAL OF CONTROLLED RELEASE
- Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques
- (2014) C. Grandin et al. JOURNAL OF GENERAL VIROLOGY
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
- (2014) Virginie Hervé et al. mAbs
- Effect of formulation on the stability and aerosol performance of a nebulized antibody
- (2014) Renaud Respaud et al. mAbs
- Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung Injury
- (2013) Pietro Roversi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- (2013) K. Tamura et al. JOURNAL OF NUCLEAR MEDICINE
- The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem
- (2013) Thomas Secher et al. PLoS One
- An Anti-Human ICAM-1 Antibody Inhibits Rhinovirus-Induced Exacerbations of Lung Inflammation
- (2013) Stephanie Traub et al. PLoS Pathogens
- Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials
- (2013) Lui G Franciosi et al. Lancet Respiratory Medicine
- The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation
- (2012) Daniel Lightwood et al. JOURNAL OF MOLECULAR BIOLOGY
- The potential of biologics for the treatment of asthma
- (2012) Girolamo Pelaia et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
- (2011) T. Secher et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inflammasome-IL-1-Th17 response in allergic lung inflammation
- (2011) A.-G. Besnard et al. Journal of Molecular Cell Biology
- Airway responsiveness in an allergic rabbit model
- (2011) S.D. Keir et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
- (2010) M. P. Horn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical and Biological Characterization of a New Oxidized Avidin with Enhanced Tissue Binding Properties
- (2010) Antonio Verdoliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- Development trends for therapeutic antibody fragments
- (2009) Aaron L Nelson et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started